Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations.

Détails

Demande d'une copieDemande d'une copie
ID Serval
serval:BIB_FF29A9470DFE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Production externe
Titre
Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations.
Périodique
Current Opinion in Oncology
Auteur⸱e⸱s
Bourhis J., Etessami A., Wilbault P., Lusinchi A., Calais G., Lapeyre M., Pignon J.P.
ISSN
1040-8746 (Print)
ISSN-L
1040-8746
Statut éditorial
Publié
Date de publication
2004
Peer-reviewed
Oui
Volume
16
Numéro
3
Pages
215-219
Langue
anglais
Notes
Publication types: Journal Article ; Review Publication Status: ppublish
Résumé
PURPOSE OF REVIEW: This article provides an overview of randomized studies of altered fractionated radiotherapy (RT) in Head and Neck squamous cell carcinoma.
RECENT FINDINGS: Both hyperfractionated RT and accelerated RT may improve tumor control probability as compared to conventional RT, along with increased but manageable toxicity and a modest improvement in survival.
SUMMARY: Altered RT is a tool that can improve the results obtained with conventional RT in Head and squamous cell carcinoma.
Mots-clé
Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Squamous Cell/mortality, Carcinoma, Squamous Cell/therapy, Combined Modality Therapy, Disease Management, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/therapy, Humans, Radiotherapy/adverse effects, Radiotherapy Dosage, Randomized Controlled Trials as Topic, Risk Assessment, Survival Rate
Pubmed
15069315
Web of science
000221149900003
Création de la notice
01/12/2014 18:54
Dernière modification de la notice
20/08/2019 17:29
Données d'usage